Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Cancer Medicine
|
April 10, 2024
Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
Helmneh M Sineshaw, Christina M Zettler, Jennifer Prescott, et al.
JCO Clinical Cancer Informatics
|
April 16, 2025
Validation of a Composite Real-World Mortality Variable Among Patients With Hematologic Malignancies Treated in the United States
Sharlene Dong, Ankit Kansagra, Gurbakhash Kaur, et al.
Blood Advances
|
February 3, 2022
Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
Bindu Kanapuru, Laura L Fernandes, Lola A Fashoyin-Aje, et al.
Blood Neoplasia
|
June 23, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States
Matthew S Davids, Jacob Ambrose, Enrico de Nigris, et al.
JCO Oncology Practice
|
May 9, 2025
Treatment Patterns and Real-World Outcomes of Molecular Subgroups in Patients With AML Receiving Frontline Venetoclax-Based Therapy
Curtis A Lachowiez, Anna Barcellos, Christina M Zettler, et al.
Blood Cancer Journal
|
April 20, 2022
Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
Kathleen Maignan, Lola A Fashoyin-Aje, Aracelis Z Torres, et al.
JCO Oncology Practice
|
April 30, 2026
Real-World Treatment Patterns and Outcomes Among Patients With Newly Diagnosed AML in the United States
Elizabeth Dianne Pulte, Laura L Fernandes, Kelly Norsworthy, et al.
The Oncologist
|
December 14, 2018
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
Daniel L Suzman, Sundeep Agrawal, Yang-Min Ning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
V Ellen Maher, Laura L Fernandes, Chana Weinstock, et al.
American Journal of Hematology
|
December 13, 2025
Real-World Outcomes and Treatment Patterns in Patients With Acute Myeloid Leukemia and TP53 Gene Mutation or 17p Deletion
Rebecca Bystrom, Laura L Fernandes, Joseph Wynne, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Cancer Medicine
|
April 10, 2024
Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
Helmneh M Sineshaw, Christina M Zettler, Jennifer Prescott, et al.
JCO Clinical Cancer Informatics
|
April 16, 2025
Validation of a Composite Real-World Mortality Variable Among Patients With Hematologic Malignancies Treated in the United States
Sharlene Dong, Ankit Kansagra, Gurbakhash Kaur, et al.
Blood Advances
|
February 3, 2022
Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
Bindu Kanapuru, Laura L Fernandes, Lola A Fashoyin-Aje, et al.
Blood Neoplasia
|
June 23, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States
Matthew S Davids, Jacob Ambrose, Enrico de Nigris, et al.
JCO Oncology Practice
|
May 9, 2025
Treatment Patterns and Real-World Outcomes of Molecular Subgroups in Patients With AML Receiving Frontline Venetoclax-Based Therapy
Curtis A Lachowiez, Anna Barcellos, Christina M Zettler, et al.
Blood Cancer Journal
|
April 20, 2022
Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
Kathleen Maignan, Lola A Fashoyin-Aje, Aracelis Z Torres, et al.
JCO Oncology Practice
|
April 30, 2026
Real-World Treatment Patterns and Outcomes Among Patients With Newly Diagnosed AML in the United States
Elizabeth Dianne Pulte, Laura L Fernandes, Kelly Norsworthy, et al.
The Oncologist
|
December 14, 2018
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
Daniel L Suzman, Sundeep Agrawal, Yang-Min Ning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
V Ellen Maher, Laura L Fernandes, Chana Weinstock, et al.
American Journal of Hematology
|
December 13, 2025
Real-World Outcomes and Treatment Patterns in Patients With Acute Myeloid Leukemia and TP53 Gene Mutation or 17p Deletion
Rebecca Bystrom, Laura L Fernandes, Joseph Wynne, et al.
Page
of 3